Osteosarcoma in very young children

Cancer

Volumn 116, Issue 22, 2010, Pages 5316-5324

  Kager, Leo ^a   Zoubek, Andreas ^a   Dominkus, Martin ^b   Lang, Susanna ^b   Bodmer, Nicole ^c   Jundt, Gernot ^d   Klingebiel, Thomas ^e   Jürgens, Heribert ^f   Gadner, Helmut ^a   Bielack, Stefan ^g  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e GOETHE UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^g OLGAHOSPITAL   (Germany)

Author keywords

osteosarcoma; outcome; treatment; young children

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; TROFOSFAMIDE; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CHILD; CLINICAL ARTICLE; DRUG MEGADOSE; EVENT FREE SURVIVAL; FEMALE; HUMAN; MALE; METASTASIS; OSTEOSARCOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD;

ARM; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD, PRESCHOOL; FEMALE; HUMANS; LEG; MALE; NEOPLASM METASTASIS; OSTEOSARCOMA; TREATMENT OUTCOME;

EID: 78449279896     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25287     Document Type: Article

References (34)

1. Mirabello L, Troisi RJ, Savage SA., Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009; 115: 1531-1543.
2. Mascarenhas L, Siegel S, Spector L, Arndt C, Femino D, Malogolowkin M., Malignant bone tumors: cancer in 15-to 29-year-olds in the United States. In:, Bleyer A, Barr R, Ries LAG, eds. Cancer Epidemiology in Older Adolescents and Young adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. Bethesda, Md: National Cancer Institute; 2006: 98-109. NIH Pub. No. 06-5767. 2006.
3. Hartford CM, Wodowski KS, Rao BN, Khoury JD, Neel MD, Daw NC., Osteosarcoma among children aged 5 years or younger: the St. Jude Children's Research Hospital experience. J Pediatr Hematol Oncol. 2006; 28: 43-47.
4. Siegal GP, Dahlin DC, Sim FH., Osteoblastic osteogenic sarcoma in a 35-month-old girl. Report of a case. Am J Clin Pathol. 1975; 63: 886-890.
5. Barwick KW, Huvos AG, Smith J., Primary osteogenic sarcoma of the vertebral column: a clinicopathologic correlation of ten patients. Cancer. 1980; 46: 595-604.
6. Atik OS, Caglar M, Bolukbasi S, Gogus S, Gogus MT., Osteogenic sarcoma of the distal femur in a young child. Hum Pathol. 1982; 13: 766.
7. Levy ML, Jaffe N., Osteosarcoma in early childhood. Pediatrics. 1982; 70: 302-303.
8. Kolandaivelu G, Soundararajan P, Radhakrishnan S, Manohar K., Osteosarcoma in an infant. Indian Pediatr. 1986; 23 (2): 141-143.
9. Lim Tan SK, Khong KS., Osteosarcoma in a 14 month old female child. Ann Acad Med Singapore. 1986; 15: 87-91.
10. Buhrer C, Weinel P, Sauter S, Reiter A, Riehm H, Laszig R., Acute onset deafness in a 4-year-old girl after a single infusion of cis-platinum. Pediatr Hematol Oncol. 1990; 7: 145-148.
11. Kozakewich H, Perez-, Atayde AR, Goorin AM, Wilkinson RH, Gebhardt MC, Vawter GF., Osteosarcoma in young children. Cancer. 1991; 67: 638-642.
12. Luiz CP, al, Kharusi W, Sethu AU, Buhl L, al, Lamki Z., Osteosarcoma in a 26-month-old girl. Cancer. 1992; 70: 894-896.
13. Sanchis,-Alfonso V, Fernandez-Fernandez CI, Donat J, Llombart,-Bosch A., Osteoblastic osteogenic sarcoma in a 13-month-old girl. Pathol Res Pract. 1994; 190: 207-210; discussion 11.
14. Graham NJ, Cairns RA, Anderson RA., Osteosarcoma in a 19-month-old girl. Can Assoc Radiol J. 1996; 47: 33-35.
15. Ibrahim S, Sundari MN, Masir N., Osteosarcoma in a sixteen-month old boy. Med J Malaysia. 1999; 54: 261-263.
16. Lipton JM, Federman N, Khabbaze Y, et al. Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry. J Pediatr Hematol Oncol. 2001; 23: 39-44.
17. Rivera-Luna R, De Leon-, Bojorge B, Ruano,-Aguilar J, Castellanos A, Vazquez C., Osteosarcoma in children under three years of age. Med Pediatr Oncol. 2003; 41: 99-100.
18. Winkler K, Beron G, Schellong G, et al. [Cooperative osteosarcoma study COSS-77: results after 4 years]. Klin Padiatr. 1982; 194: 251-256.
19. Winkler K, Beron G, Kotz R, et al. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study. J Clin Oncol. 1984; 2: 617-624.
20. Winkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol. 1988; 6: 329-337.
21. Fuchs N, Bielack SS, Epler D, et al. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol. 1998; 9: 893-899.
22. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002; 20: 776-790.
23. Salzer-Kuntschik M, Delling G, Beron G, Sigmund R., Morphological grades of regression in osteosarcoma after polychemotherapy-study COSS 80. J Cancer Res Clin Oncol. 1983; 106 (suppl): 21-24.
24. Goldin AS, A, A,;, Mantel, N,. Experimental screening procedures and clinical predictability value. Cancer Chemother Rep. 1966; 50: 173-218.
25. Winkelmann WW., Type-B-IIIa hip rotationplasty: an alternative operation for the treatment of malignant tumors of the femur in early childhood. J Bone Joint Surg Am. 2000; 82: 814-828.
26. Chauveinc L, Mosseri V, Quintana E, et al. Osteosarcoma following retinoblastoma: age at onset and latency period. Ophthalmic Genet. 2001; 22: 77-88.
27. Price CH., Primary bone-forming tumours and their relationship to skeletal growth. J Bone Joint Surg Br. 1958; 40-B: 574-593.
28. Grimer RJ, Carter SR, Tillman RM, Abudu A., Early symptoms and diagnosis of bone tumors. J Bone Joint Surg Am. 2001; 83-A: 1107-1108.
29. Kager L, Zoubek A, Potschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003; 21: 2011-2018.
30. Marina N, Gebhardt M, Teot L, Gorlick R., Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004; 9: 422-441.
31. Weiss A, Khoury JD, Hoffer FA, et al. Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience. Cancer. 2007; 109: 1627-1637.
32. Picci P, Sangiorgi L, Rougraff BT, Neff JR, Casadei R, Campanacci M., Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol. 1994; 12: 2699-2705.
33. Kempf-Bielack B, Bielack SS, Jurgens H, et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol. 2005; 23: 559-568.
34. Bielack SS, Kempf-Bielack B, Branscheid D, et al. Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol. 2009; 27: 557-565.